AR111146A2 - Compuesto de metal mixto y composición farmacéutica que lo comprende - Google Patents
Compuesto de metal mixto y composición farmacéutica que lo comprendeInfo
- Publication number
- AR111146A2 AR111146A2 ARP180100782A ARP180100782A AR111146A2 AR 111146 A2 AR111146 A2 AR 111146A2 AR P180100782 A ARP180100782 A AR P180100782A AR P180100782 A ARP180100782 A AR P180100782A AR 111146 A2 AR111146 A2 AR 111146A2
- Authority
- AR
- Argentina
- Prior art keywords
- mixed metal
- pharmaceutical composition
- metal composite
- metal compound
- range
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/009—Compounds containing, besides iron, two or more other elements, with the exception of oxygen or hydrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/84—Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/20—Two-dimensional structures
- C01P2002/22—Two-dimensional structures layered hydroxide-type, e.g. of the hydrotalcite-type
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/60—Compounds characterised by their crystallite size
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/11—Powder tap density
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/14—Pore volume
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
- C01P2006/82—Compositional purity water content
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Iron (AREA)
- Medicinal Preparation (AREA)
- Manufacture And Refinement Of Metals (AREA)
Abstract
Un compuesto de metal mixto que comprende al menos Mg²⁺ y al menos Fe³⁺, donde la relación molar de Mg²⁺ a Fe³⁺ está dentro del rango de 2,5:1 a 1,5:1, un contenido de aluminio del compuesto de metal mixto es de menos de 10000 ppm, el tamaño de cristal promedio del compuesto de metal mixto está en el rango de 10 nm a 20 nm (100 a 200 Å), y un área de superficie de 40 a 80 m²/g del compuesto de metal mixto.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0913525.2A GB0913525D0 (en) | 2009-08-03 | 2009-08-03 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
AR111146A2 true AR111146A2 (es) | 2019-06-05 |
Family
ID=41129559
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100102697A AR077500A1 (es) | 2009-08-03 | 2010-07-26 | Metodo para producir compuestos de metal mixtos |
ARP180100782A AR111146A2 (es) | 2009-08-03 | 2018-03-28 | Compuesto de metal mixto y composición farmacéutica que lo comprende |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100102697A AR077500A1 (es) | 2009-08-03 | 2010-07-26 | Metodo para producir compuestos de metal mixtos |
Country Status (11)
Country | Link |
---|---|
US (3) | US9314481B2 (es) |
EP (2) | EP2462062B1 (es) |
JP (3) | JP5894073B2 (es) |
CN (3) | CN106115789B (es) |
AR (2) | AR077500A1 (es) |
DK (1) | DK2462062T3 (es) |
ES (1) | ES2751325T3 (es) |
GB (1) | GB0913525D0 (es) |
PT (1) | PT2462062T (es) |
TW (3) | TWI617513B (es) |
WO (1) | WO2011015859A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
CN109985228A (zh) * | 2011-11-10 | 2019-07-09 | 凯伊药品公司 | 拟钙剂及其使用方法 |
AU2013227207B2 (en) * | 2012-03-02 | 2016-11-03 | Council Of Scientific & Industrial Research | Double fortified salt composition containing iron and iodine and process for the preparation thereof |
CN103214075B (zh) * | 2013-05-20 | 2014-08-13 | 章方军 | 一种复合絮凝剂及其制备方法和用途 |
ES2820737T3 (es) * | 2013-11-27 | 2021-04-22 | Vifor Fresenius Medical Care Renal Pharma Ltd | Composición farmacéutica que comprende partículas de quelante de fosfato |
US9592253B1 (en) * | 2015-10-14 | 2017-03-14 | ZS Pharma, Inc. | Extended use zirconium silicate compositions and methods of use thereof |
US10392267B2 (en) | 2017-04-18 | 2019-08-27 | King Abdulaziz University | Azo dye intercalated Fe(II)/Fe(III) layered double hydroxide for water purification |
EP3873490A1 (en) | 2018-10-25 | 2021-09-08 | EirGen Pharma Ltd. | Methods of treatment with mixed metal compounds |
FR3112968A1 (fr) * | 2020-07-28 | 2022-02-04 | IFP Energies Nouvelles | Procédé de préparation d'un support de catalyseur Fischer-Tropsch comprenant une étape de séchage spin flash |
Family Cites Families (146)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1001430A (en) | 1910-04-16 | 1911-08-22 | Samuel W Nesbitt | Device for dressing grinding-wheels. |
US2222924A (en) | 1936-12-10 | 1940-11-26 | Degussa | Preparation of cerium sulphate |
US2812344A (en) | 1956-02-13 | 1957-11-05 | Ortho Pharma Corp | Ferrous calcium citrate complex |
FR1214473A (fr) | 1959-01-07 | 1960-04-08 | Procédé de préparation d'un catalyseur à base d'hydroxyde de cérium | |
BE590192A (es) | 1959-04-27 | |||
US3395211A (en) | 1965-12-10 | 1968-07-30 | Carter Wallace | Tableting process |
US3539306A (en) | 1966-07-25 | 1970-11-10 | Kyowa Chem Ind Co Ltd | Process for the preparation of hydrotalcite |
US3879523A (en) | 1969-12-12 | 1975-04-22 | Kyowa Chem Ind Co Ltd | Composite metal hydroxides |
SU414849A1 (ru) | 1971-05-21 | 1977-09-05 | Харьковский домостроительный комбинат | Бетонна смесь |
BE792032A (fr) | 1971-12-23 | 1973-03-16 | Baxter Laboratories Inc | Dispositif de transfert de masse ayant une membrame semi-permeable disposee en spirale et presentant un faible volume de fluide |
NL174720C (nl) | 1973-12-13 | 1984-08-01 | Philips Nv | Beeldweergeefcel en methode voor de vervaardiging van een vloeibaar kristallijn p-n.butyl-p'-alkoxyazobenzeen. |
FR2435442A1 (fr) | 1978-09-07 | 1980-04-04 | Om Lab Sa | Silicate de magnesium et d'aluminium synthetique, procede de fabrication de celui-ci et compositions pharmaceutiques comprenant celui-ci |
US4192900A (en) | 1978-10-12 | 1980-03-11 | Merck & Co., Inc. | Texturized starch products |
DE2845326C2 (de) | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung |
DE3039997A1 (de) | 1980-10-23 | 1982-06-03 | Bayer Ag, 5090 Leverkusen | Phosphonohydroxyacetonitril, ein verfahren zu seiner herstellung und seine verwendung als zwischenprodukt fuer die herstellung von arzneimitteln |
US4351814A (en) | 1980-12-18 | 1982-09-28 | Kyowa Chemical Industry Co., Ltd. | Hydrotalcites having a hexagonal needle-like crystal structure and process for production thereof |
JPS57156419A (en) | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
US4514389A (en) | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
CA1198674A (en) | 1981-11-23 | 1985-12-31 | Rorer International (Holdings) Inc. | Antacid compositions |
US4458026A (en) | 1982-06-02 | 1984-07-03 | Union Carbide Corporation | Catalysts for aldol condensations |
US4582705A (en) | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
JPS606619A (ja) | 1983-06-27 | 1985-01-14 | Kyowa Chem Ind Co Ltd | 鉄分欠乏症処置剤及びその製法 |
GB8317595D0 (en) | 1983-06-29 | 1983-08-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US4609543A (en) | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
JPS60131604A (ja) | 1983-12-20 | 1985-07-13 | Victor Co Of Japan Ltd | 磁気記録再生素子 |
DE3346943A1 (de) | 1983-12-24 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Herstellung von hydrotalcit mit verbesserten eigenschaften |
DE3402878A1 (de) | 1984-01-27 | 1985-08-01 | Algina AG, Zug | Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel |
FR2559755A1 (fr) | 1984-02-20 | 1985-08-23 | Rhone Poulenc Spec Chim | Oxyde cerique a nouvelles caracteristiques morphologiques et son procede d'obtention |
JPS6136222A (ja) | 1984-07-26 | 1986-02-20 | Chugai Pharmaceut Co Ltd | 高リン酸血症治療剤 |
US4566986A (en) | 1984-08-31 | 1986-01-28 | Waldmann John J | Flocculating agents and processes for making them |
DE3520108A1 (de) | 1985-06-05 | 1986-12-11 | Varta Batterie Ag, 3000 Hannover | Positive sammlerelektrode fuer akkumulatoren mit alkalischem elektrolyten |
JPH06705B2 (ja) | 1985-12-19 | 1994-01-05 | 旭化成工業株式会社 | リン酸イオンの固定化剤 |
US6749864B2 (en) | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US4871392A (en) | 1986-05-23 | 1989-10-03 | American Cyanamid Company | Aqueous suspension concentrate compositions of pendimethalin |
US4801454A (en) | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
DE3864932D1 (de) | 1987-06-29 | 1991-10-24 | Rhone Poulenc Chimie | Verfahren zur gewinnung eines ceriumoxids. |
US4786510A (en) | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
US4994283A (en) | 1987-07-02 | 1991-02-19 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
DE3801382A1 (de) | 1988-01-19 | 1989-08-03 | Ebner Anlagen & Apparate | Verfahren und anlage zur umwandlung von natriumsulfat in natriumhydroxid |
DE68916983T2 (de) | 1988-02-25 | 1995-01-19 | Yamanouchi Europ Bv | Verfahren zur Herstellung eines pharmazeutischen Granulats. |
HU201880B (en) | 1988-06-21 | 1991-01-28 | Semmelweis Orvostudomanyi Egye | Process for producing pharmaceutical compositions for profilacting and treating renal diseases and for diminishing frequency of extracorporalis dialysis |
GB8826333D0 (en) | 1988-11-10 | 1988-12-14 | Unilever Plc | Oral compositions |
US5153156A (en) | 1989-04-18 | 1992-10-06 | Aristech Chemical Corporation | Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone |
FR2647433B1 (fr) | 1989-05-23 | 1991-10-31 | Lafarge Coppee Da | Procede de preparation par voie aqueuse de sulfate de calcium purifie |
US4970079A (en) | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
US5112604A (en) | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
ES2018952A6 (es) | 1989-10-17 | 1991-05-16 | Walton Sa | Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica. |
JP2918619B2 (ja) * | 1990-04-06 | 1999-07-12 | 花王株式会社 | 金属磁性粉末の製造方法及び磁気記録媒体用塗膜 |
EP0532613B1 (en) | 1990-06-08 | 1996-04-17 | Commonwealth Scientific And Industrial Research Organisation | Ethylene sorbing substances |
US5300302A (en) | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package |
DE4036757A1 (de) | 1990-11-17 | 1992-05-21 | Bayer Ag | Antazida-zubereitung mit verlaengerter magenverweilzeit |
GB2253164B (en) | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
GB2254556B (en) | 1991-04-11 | 1995-04-12 | Fisons Plc | Formulations containing linolenic acid |
US5246899A (en) | 1991-08-16 | 1993-09-21 | Amoco Corporation | Simplified preparation of hydrotalcite-type clays |
JPH05155776A (ja) | 1991-12-02 | 1993-06-22 | Otsuka Pharmaceut Factory Inc | 高リン血症治療剤 |
JPH05208816A (ja) | 1992-01-28 | 1993-08-20 | Sumitomo Metal Mining Co Ltd | 水酸化セリウム及び酸化セリウムの製造方法 |
WO1993022237A1 (en) | 1992-04-30 | 1993-11-11 | J.M. Huber Corporation | Method for production of synthetic hydrotalcite |
US5380542A (en) | 1992-06-19 | 1995-01-10 | Rhone-Poulenc Specialties Chemical Co. | Dietary fiber compositions for use in foods |
US5273767A (en) | 1992-09-09 | 1993-12-28 | Merck & Co., Inc. | Rapidly hydrating gums |
US5364828A (en) * | 1992-10-21 | 1994-11-15 | Minerals Technologies | Spheroidal aggregate of platy synthetic hydrotalcite |
AU5589594A (en) | 1992-10-29 | 1994-05-24 | C-P Technology Limited Partnership | Mixtures or complexes containing calcium and sulfate |
NL9201907A (nl) | 1992-11-02 | 1994-06-01 | Tno | Peristaltisch mengende reactor en peristaltische kleppenpomp. |
DE4239442C2 (de) | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
CA2110313C (en) | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
JP3395254B2 (ja) * | 1993-05-28 | 2003-04-07 | 住友金属鉱山株式会社 | 非焼結式アルカリ蓄電池用水酸化ニッケルの製造方法 |
US5506248A (en) | 1993-08-02 | 1996-04-09 | Bristol-Myers Squibb Company | Pharmaceutical compositions having good dissolution properties |
TW397686B (en) | 1993-08-11 | 2000-07-11 | Takeda Chemical Industries Ltd | Antacid compositions and pharmaceutical compositions |
WO1995011033A1 (en) | 1993-10-22 | 1995-04-27 | Commonwealth Scientific And Industrial Research Organisation | Polyoxometallates in the treatment of flavivirus infections |
TW390813B (en) | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
CA2199027C (en) | 1994-09-21 | 2001-02-20 | Peter George Vernon | Oral compositions |
DE19503522A1 (de) * | 1995-02-03 | 1996-08-08 | Rwe Dea Ag | Herstellung gemischter schichtförmig aufgebauter Metallhydroxide sowie deren Metalloxide |
GB9506126D0 (en) | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
DE69637681D1 (de) | 1995-09-20 | 2008-10-23 | Univ Queensland St Lucia | Nukleotidsequenzen welche für ACC Synthase Enzyme aus Papaya kodieren |
US5571336A (en) | 1995-09-29 | 1996-11-05 | Wurzburger; Stephen R. | Base solution for cleaning aluminum |
DE19547356A1 (de) | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
GB2316006B (en) | 1996-01-25 | 1998-11-18 | Colin Leslie Young | Stomach-action molluscicides |
SE9602442D0 (sv) | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
RU2189227C2 (ru) | 1996-07-12 | 2002-09-20 | Дайити Фармасьютикал Ко., Лтд. | Быстро распадающиеся прессованные в формах материалы и способ их получения |
US5654011A (en) | 1996-07-30 | 1997-08-05 | Energetics, Inc. | Dietary supplements |
JPH1059842A (ja) | 1996-08-13 | 1998-03-03 | Lion Corp | 錠剤用組成物及び打錠方法 |
JPH10101569A (ja) * | 1996-10-01 | 1998-04-21 | Eisai Co Ltd | 制酸剤 |
JPH10236960A (ja) | 1997-02-24 | 1998-09-08 | Lion Corp | 制酸剤含有組成物 |
TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US6028023A (en) | 1997-10-20 | 2000-02-22 | Bulldog Technologies U.S.A., Inc. | Process for making, and use of, anionic clay materials |
AU741992B2 (en) | 1998-03-06 | 2001-12-13 | Adare Pharmaceuticals S.R.L. | Fast disintegrating tablets |
JPH11335269A (ja) | 1998-05-19 | 1999-12-07 | Hisamitsu Pharmaceut Co Inc | 遺伝子関連医薬の経口投与固形製剤 |
JP2000086537A (ja) | 1998-09-11 | 2000-03-28 | Fuji Chem Ind Co Ltd | 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法 |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
KR100331529B1 (ko) | 1999-06-16 | 2002-04-06 | 민경윤 | 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법 |
US6448323B1 (en) | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
US6177581B1 (en) | 1999-10-12 | 2001-01-23 | The Dow Chemical Company | Mixed-metal chelates and process for the preparation thereof |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
DE19958007A1 (de) | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen |
EP1246629A4 (en) | 2000-01-06 | 2007-04-18 | Marantech Holding Llc | METHODS USING ACTIVE ELECTRON COMPOUNDS FOR MANAGING CANCER CONDITIONS |
AUPQ533700A0 (en) | 2000-01-28 | 2000-02-17 | Commonwealth Scientific And Industrial Research Organisation | Soil treatment method |
JP4439067B2 (ja) * | 2000-02-23 | 2010-03-24 | 三菱原子燃料株式会社 | 鉄系複水酸化物の製造方法及び該複水酸化物を用いた水処理材 |
JP4762399B2 (ja) * | 2000-05-09 | 2011-08-31 | ライオン株式会社 | アルコキシル化用触媒およびその製造方法並びにこの触媒を用いるアルキレンオキサイド付加物の製造方法 |
US20030185886A1 (en) | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
FR2809407B1 (fr) | 2000-05-26 | 2002-08-30 | Rhodia Chimie Sa | Utilisation d'hydrotalcite comme charge dans des compositions de polymeres |
US6720005B1 (en) | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
US6576665B2 (en) | 2001-04-03 | 2003-06-10 | Braintree Laboratories, Inc. | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
WO2003003809A2 (en) | 2001-07-05 | 2003-01-16 | Marantech Holding, Llc | Methods of using electron active compounds for managing conditions afflicting mammals |
UA80682C2 (en) | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
DK1421944T3 (da) | 2001-08-27 | 2008-03-31 | Kyowa Chem Ind Co Ltd | Antacid- og laksativtablet |
AR036354A1 (es) | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
WO2003028706A1 (fr) | 2001-09-28 | 2003-04-10 | Sanwa Kagaku Kenkyusho Co.,Ltd | Double comprime a desintegration rapide |
GB0204771D0 (en) | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
US7300670B2 (en) | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
UA75831C2 (en) | 2002-04-29 | 2006-05-15 | Egyt Gyogyszervegyeszeti Gyar | Process for preparation of tablets from pharmaceutically active ingredients having unfavourable tabletting properties with the use of granulating liquid containing microcrystalline cellulose |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
EP1551882B1 (en) | 2002-06-25 | 2016-05-11 | Solvay USA Inc. | Molecular weight reduction of polysaccharides by electron beams |
WO2004018094A1 (en) | 2002-08-09 | 2004-03-04 | Albemarle Netherlands B.V. | Fischer-tropsch process using an iron-containing layered material |
JP4348426B2 (ja) | 2002-08-29 | 2009-10-21 | 独立行政法人産業技術総合研究所 | 高選択性脱リン剤及びその製造方法 |
WO2005012194A1 (en) | 2003-01-28 | 2005-02-10 | The University Of Wyoming Research Corporation D/B/A Western Research Institute | Charge-based water filtration systems |
CN1798699B (zh) * | 2003-05-30 | 2010-11-10 | 杰富意矿物股份有限公司 | 金属复合氧化物的制造方法 |
CA2562014C (en) * | 2003-07-07 | 2014-02-11 | Instituto Mexicano Del Petroleo | Method of obtaining multimetallic oxides derived from hydrotalcite-type compounds |
AR045068A1 (es) | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
EP2792363B1 (en) | 2003-08-26 | 2016-06-29 | Shire Biopharmaceuticals Holdings Ireland Limited | Pharmaceutical formulation comprising lanthanum compounds |
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
EP1696889A1 (en) | 2003-08-28 | 2006-09-06 | Ranbaxy Laboratories, Ltd. | Pharmaceutical compositions of benzimidazole and processes for their preparation |
JP4702512B2 (ja) * | 2003-09-19 | 2011-06-15 | 戸田工業株式会社 | ハイドロタルサイト類化合物粒子粉末及び該ハイドロタルサイト類化合物粒子粉末を含有する水系分散体 |
KR101169481B1 (ko) * | 2004-03-16 | 2012-07-27 | 니폰 고쿠도 가이하츠 가부시키가이샤 | 하이드로탈사이트형 물질 및 그 제조 방법, 및 유해 물질의고정화 방법 |
US20050260271A1 (en) | 2004-05-20 | 2005-11-24 | Eastman Kodak Company | Composition comprising layered host material with intercalated functional-active organic compound |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
ZA200705375B (en) * | 2004-12-23 | 2008-12-31 | Commw Scient Ind Res Org | Heat treatment of aluminium alloy high pressure die castings |
US20090108233A1 (en) * | 2004-12-24 | 2009-04-30 | The Univeristy Of Queensland | Preparation of suspensions |
GB0502787D0 (en) | 2005-02-10 | 2005-03-16 | Ineos Silicas Ltd | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use |
JP4823547B2 (ja) | 2005-03-28 | 2011-11-24 | 株式会社ジーシー | ペースト状歯科用アルギン酸塩印象材組成物 |
CA2634969A1 (en) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Controlled release solid preparation |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
JP4899182B2 (ja) * | 2006-03-22 | 2012-03-21 | 独立行政法人産業技術総合研究所 | アニオン交換体の製造方法 |
PL2034958T3 (pl) | 2006-05-19 | 2010-04-30 | Norbrook Lab Ltd | Stabilna, wodna zawiesina o przyjemnym smaku |
EP2319804B1 (en) | 2006-12-14 | 2014-10-22 | Novartis AG | Iron(III)-Carbohydrate based phosphate adsorbent |
PT2319804E (pt) | 2006-12-14 | 2014-11-24 | Novartis Ag | Adsorvente de fosfato à base de ferro (iii)-carboidrato |
CN101049953A (zh) * | 2007-01-12 | 2007-10-10 | 北京化工大学 | 一种层状双羟基复合金属氧化物微球及其制备方法 |
EP1946750A1 (en) | 2007-01-18 | 2008-07-23 | The Jordanian Pharmaceutical Manufacturing Co. | Co-precipitate, method for preparing the same and uses thereof |
WO2008129034A1 (en) | 2007-04-20 | 2008-10-30 | Euro Support Catalyst Group Bv | Hydrotalcite-like layered double hydroxide (ldh) composition and process of making same |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
JP2009034564A (ja) * | 2007-07-31 | 2009-02-19 | Jdc Corp | アルカリ溶液中でイオン化する物質xの吸着剤および分離方法 |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
DE102007059990A1 (de) * | 2007-12-13 | 2009-06-18 | Süd-Chemie AG | Verfahren zur Herstellung nanokristalliner Hydrotalcitverbindungen |
SG173887A1 (en) * | 2009-03-02 | 2011-10-28 | Vifor Int Ag | Phosphate adsorbent |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
-
2009
- 2009-08-03 GB GBGB0913525.2A patent/GB0913525D0/en not_active Ceased
-
2010
- 2010-07-09 TW TW099122681A patent/TWI617513B/zh not_active IP Right Cessation
- 2010-07-09 TW TW106136737A patent/TWI649267B/zh not_active IP Right Cessation
- 2010-07-09 TW TW105116495A patent/TWI619677B/zh not_active IP Right Cessation
- 2010-07-26 AR ARP100102697A patent/AR077500A1/es active IP Right Grant
- 2010-08-02 PT PT107399875T patent/PT2462062T/pt unknown
- 2010-08-02 EP EP10739987.5A patent/EP2462062B1/en active Active
- 2010-08-02 EP EP19186506.2A patent/EP3611131A1/en active Pending
- 2010-08-02 JP JP2012523389A patent/JP5894073B2/ja active Active
- 2010-08-02 US US13/388,476 patent/US9314481B2/en active Active
- 2010-08-02 CN CN201610371464.2A patent/CN106115789B/zh active Active
- 2010-08-02 WO PCT/GB2010/051271 patent/WO2011015859A1/en active Application Filing
- 2010-08-02 CN CN201910277263.XA patent/CN110357165B/zh active Active
- 2010-08-02 DK DK10739987.5T patent/DK2462062T3/da active
- 2010-08-02 CN CN201080040879.2A patent/CN102498068B/zh active Active
- 2010-08-02 ES ES10739987T patent/ES2751325T3/es active Active
-
2014
- 2014-03-24 US US14/224,040 patent/US9066917B2/en active Active
-
2015
- 2015-05-07 JP JP2015095095A patent/JP6049801B2/ja active Active
-
2016
- 2016-04-19 US US15/133,206 patent/US20160296557A1/en active Pending
- 2016-11-22 JP JP2016226924A patent/JP6333926B2/ja active Active
-
2018
- 2018-03-28 AR ARP180100782A patent/AR111146A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3611131A1 (en) | 2020-02-19 |
CN110357165B (zh) | 2022-05-13 |
AR077500A1 (es) | 2011-08-31 |
GB0913525D0 (en) | 2009-09-16 |
JP2013500933A (ja) | 2013-01-10 |
CN106115789B (zh) | 2019-05-03 |
CN106115789A (zh) | 2016-11-16 |
TWI619677B (zh) | 2018-04-01 |
TWI617513B (zh) | 2018-03-11 |
EP2462062B1 (en) | 2019-07-17 |
US20160296557A1 (en) | 2016-10-13 |
CN102498068B (zh) | 2016-06-29 |
TW201630818A (zh) | 2016-09-01 |
EP2462062A1 (en) | 2012-06-13 |
TW201114691A (en) | 2011-05-01 |
JP6333926B2 (ja) | 2018-05-30 |
JP2015171998A (ja) | 2015-10-01 |
CN110357165A (zh) | 2019-10-22 |
ES2751325T3 (es) | 2020-03-31 |
JP6049801B2 (ja) | 2016-12-21 |
WO2011015859A1 (en) | 2011-02-10 |
CN102498068A (zh) | 2012-06-13 |
US9314481B2 (en) | 2016-04-19 |
DK2462062T3 (da) | 2019-10-21 |
TWI649267B (zh) | 2019-02-01 |
JP5894073B2 (ja) | 2016-03-30 |
US20120201864A1 (en) | 2012-08-09 |
TW201829317A (zh) | 2018-08-16 |
US20140205667A1 (en) | 2014-07-24 |
JP2017061410A (ja) | 2017-03-30 |
US9066917B2 (en) | 2015-06-30 |
PT2462062T (pt) | 2019-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR111146A2 (es) | Compuesto de metal mixto y composición farmacéutica que lo comprende | |
UA109122C2 (uk) | Синергічна гербіцидна композиція, яка містить амінопіралід і 2,4-дихлорфеноксіоцтову кислоту | |
BRPI0910182B8 (pt) | composto de fórmula (i), composição farmacêutica e uso de um composto | |
JO2641B1 (en) | Pharmaceutical compounds containing calcium rosofastatin | |
WO2013179307A3 (en) | Stabilized pharmaceutical compositions of saxagliptin | |
MA33768B1 (fr) | Triazolopyridines | |
BR112014029754B1 (pt) | soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição | |
TW201130092A (en) | Substrate for mounting light-emitting element, and light-emitting device | |
ATE472941T1 (de) | Salzersatzmischung mit vermindertem nacl-gehalt | |
TW200718740A (en) | Compositions effective to suppress void formation | |
BR112012024783A2 (pt) | composição de combustível diesel à base de éter dietílico | |
PE20140621A1 (es) | Mejoras en o relacionadas con composiciones cementicias | |
MX347432B (es) | Composiciones activas de antitranspirante y fabricacion de las mismas. | |
AR081165A1 (es) | Composicion dental | |
FR2987834B1 (fr) | Composition hydraulique a faible teneur en clinker | |
BR112013032743A2 (pt) | parafuso | |
DOP2010000088A (es) | Compuesto inhibidor de fosforilasa de glicógeno y composición farmacéutica del mismo. | |
BR112015024878A2 (pt) | material de fio de aço com elevada resistência apresentando excelentes propriedades de estiramento a frio e fio de aço com elevada resistência | |
CL2008003602A1 (es) | Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos. | |
WO2010023473A3 (en) | Crystalline form of sunitinib and processes for its preparation | |
BR112014007829A2 (pt) | composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio | |
MY189261A (en) | A metal modified y zeolite, its preparation and use | |
MX2016003563A (es) | Acero para pernos de alta resistencia que tiene excelente resistencia a la fractura retardada y capacidad de formacion de pernos, y pernos. | |
EA200801572A1 (ru) | Фармацевтическая композиция, содержащая аморфный аторвастатин | |
WO2010062205A4 (en) | Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol |